Equities

ELQ SA

  • Add to watchlist
  • Add to portfolio
  • Add an alert

ELQ SA

Actions
  • Price (EUR)0.555
  • Today's Change0.005 / 0.91%
  • Shares traded25.00
  • 1 Year change-10.19%
  • Beta0.6733
Data delayed at least 15 minutes, as of Feb 13 2026 14:25 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

ELQ SA, formerly Spark Medical SA, is a Poland-based company engaged in the business support services industry. It offers public and investor relations consulting services for enterprises and is active primarily in the field of Internet, publishing and marketing. It owns such Web portals as IPO.PL, Excluzive.pl and Nowebiuro.pl, among others. It organizes chats, conferences and seminars for management and investors. In addition it provides environmental services, such as waste management and produces medical equipment. It also acts as pharmaceutical preparations wholesaler. It, through a wholly owned subsidiary Florida Investments X Corp, provides support activities to process of investment in residential real estates located in the United States, including searching, buying, modernizing and selling or renting property. The investments are held through special purpose vehicles (SPV) that are owned by the investors. The main shareholder of the Company is Veltoro Sp z o o.

  • Revenue in PLN (TTM)81.17m
  • Net income in PLN3.66m
  • Incorporated2010
  • Employees95.00
  • Location
    ELQ SAul. Jagiellonska 81/83CZESTOCHOWA 42-200PolandPOL
  • Phone+48 343661439
  • Fax+48 343661439
  • Websitehttps://elq.pl/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.